Palisade Bio (PALI) has had the lowest return since May 12, 2021 by a small-cap US stock, returning -99.9%.
| ASSET | % RETURN |
|---|---|
Palisade Bio (PALI) | -99.95% |
Eightco (ORBS) | -99.94% |
Avalo Therapeutics (AVTX) | -99.78% |
Meihua International Medical Technologies (MHUA) | -99.77% |
Falcon's Beyond Global, Inc Class A Common Stock (FBYD) | -99.51% |
Canopy Growth (CGC) | -99.5% |
Wheels Up Experience (UP) | -99.31% |
Andretti Acquisition Corp II Class A Ordinary Shares (POLE) | -99.31% |
P3 Health Partners (PIII) | -99.2% |
Beyond Meat (BYND) | -99.19% |
NovaBay Pharmaceuticals (NBY) | -98.83% |
AMC Entertainment (AMC) | -98.47% |
Uxin (UXIN) | -98.43% |
X4 Pharmaceuticals (XFOR) | -98.36% |
Sharplink Gaming (SBET) | -98.32% |
Highest Performances (MAAS) | -98.28% |
Ginkgo Bioworks (DNA) | -97.77% |
Amber International (AMBR) | -97.7% |
Oatly Group AB ADR (OTLY) | -97.31% |
Roboai (AIIO) | -96.88% |
New Fortress Energy LLC (NFE) | -96.76% |
Strive Asset Management (ASST) | -96.5% |
FuelCell Energy (FCEL) | -96.41% |
CureVac (CVAC) | -95.22% |
Allogene Therapeutics (ALLO) | -95.18% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
